However, targetted deletion of the Syk gene in microglia exacerbated pathology in an amyloid model of AD and in a demyelinating model of multiple sclerosis, apparently by reducing microglial phagocytosis of amyloid and myelin debris (Ennerfelt et al., 2022). This evidence concerns the gene SYK and Alzheimer disease.